((alipay))
Echizen, H. (2015). The First-in-Class Potassium-Competitive Acid Blocker, Vonoprazan Fumarate: Pharmacokinetic and Pharmacodynamic Considerations. Clinical Pharmacokinetics, 55(4), 409–418. doi:10.1007/s40262-015-0326-7
10.1007/s40262-015-0326-7
